Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
3
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicaid
3
×
national blog main
3
×
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
deals
fda
johnson & johnson
madrigal pharmaceuticals
national
nonalcoholic steatohepatitis
aducanumab
affordable care act
aimmune therapeutics
aldeyra therapeutics
alex azar
allergy
What
drug
3
×
roundup
aducanumab
agency
ahead
aimmune
allergy
alzheimer’s
ambien
american
amyloid
angst
annual
approval
approved
asco
attendees
attention
awarded
bagged
billions
bio
biogen
biogen’s
biotech
brammer
camp’s
cancer
cash
chicago
city
clinical
combinations
community’s
days
developed
effects
expanding
failure
fda
Language
unset
Current search:
medicaid
×
drug
×
" national blog main "
×
" clinical trials "
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
